Viewing StudyNCT03403777



Ignite Creation Date: 2024-05-06 @ 11:01 AM
Last Modification Date: 2024-10-26 @ 12:38 PM
Study NCT ID: NCT03403777
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2018-01-02

Brief Title: Avelumab in Refractory Testicular Germ Cell Cancer
Sponsor: National Cancer Institute Slovakia
Organization: National Cancer Institute Slovakia

Conditions & Keywords Data

Conditions:
Name
Testicular Neoplasms
Neoplasms Germ Cell and Embryonal
Neoplasms
Testicular Diseases
Gonadal Disorders
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Keywords:
Name View
Anti PD-L1 View
Multiple relapsedrefractory testicular germ cell tumors View
Avelumab View